MEDNAX

mednax.com

MEDNAX is a physician-led health solutions partner providing the highest quality patient care through our national network of nearly 3,000 physicians. Our physician practices and business professionals are passionate about taking great care of patients, continually optimizing performance and helping providers overcome healthcare’s quality, financial and administrative complexities. Physicians and advanced practitioners practicing as part of MEDNAX are reshaping the delivery of care within their specialties and subspecialties, using evidence-based tools, continuous quality initiatives, clinical research to enhance patient outcomes and provide high-quality, cost-effective care. The Company was founded in 1979, and today, through its affiliated professional corporations, MEDNAX provides services through a network of more than 3,200 physicians in all 50 states and Puerto Rico. In addition to its national physician network, MEDNAX provides services to healthcare facilities and physicians in over 40 states through two complementary businesses, consisting of a revenue cycle management company and a consulting services company.

C-Suite On Deck

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Events

2024 Geneva Health Forum Conference

Conference

The 10th International Conference on Public Health

Conference

Health Care Facilities Innovation Conference

Conference

Healthcare Marketing & Physician Strategies Summit

Conference

Related News

Health Technology

BEARPAC MEDICAL RECEIVED INVENTIVE TECHNOLOGY CONTRACT FOR THE PASSIO PUMP DRAINAGE SYSTEM FROM VIZIENT

Bearpac Medical, LLC | March 16, 2022

Bearpac Medical, LLC announced that Vizient, Inc., the nation's leading member-driven healthcare performance improvement organization, has awarded Bearpac Medical, LLC an Innovative Technology contract for their Passio Pump Drainage System. The contract was awarded based on hospital experts serving on one of Vizient's member-led councils recommending the Passio Pump Drainage System. It demonstrates to Vizient members that the Passio Pump Drainage System possesses unique characteristic...

3 WAYS TO ENHANCE HEALTHCARE INTEROPERABILITY WITH HEALTH IT

EHRIntelligence | February 10, 2020

Despite advances in health information technology, interoperability in the healthcare world is an area that needs to improve to benefit the providers and especially patient wellness. In a recent ONC data brief, researchers analyzed data from the National EHR Surveys from 2015 to 2017 and came to the conclusion that interoperability has been somewhat stagnant over the two year time period. In fact, only about 10 percent of physicians were able to send, receive, and integrate health data into thei...

Digital Healthcare

HERO AND ADHEREHEALTH ESTABLISH STRATEGIC PARTNERSHIP TO IMPROVE MEDICATION ADHERENCE AMONG VULNERABLE PATIENTS

AdhereHealth | December 18, 2021

AdhereHealth, a healthcare technology leader in medication adherence insights and health outcomes, has entered into a strategic partnership with Hero, the market leader in digital in-home care. This new agreement enables AdhereHealth to deploy Hero's digital in-home care platform to help high-risk, high-cost, chronically ill patients adhere to complex medication regimens. Hero's platform includes a connected smart pill dispenser, which automatically sorts and dispenses medic...

Future of Healthcare

MEDICAGO ANNOUNCES PUBLICATION OF PHASE 3 COVID-19 VACCINE STUDY RESULTS IN NEW ENGLAND JOURNAL OF MEDICINE

Medicago | May 06, 2022

Medicago announced the publication of the results from the Phase 3 study of COVIFENZ®, COVID-19 vaccine recombinant, adjuvanted, in the New England Journal of Medicine. The Phase 3 trial studied the two-dose regimen of COVIFENZ® given 21 days apart versus placebo in over 24,000 subjects aged 18 and above. Common side effects in the vaccine group included injection site pain, headache, fatigue, fever, muscle aches, and chills. COVIFENZ® is indicated for active immunizatio...

Health Technology